Table 1

Subject characteristics (N=292)

Characteristics
Age (years)Mean±SD65.6±14.3
Median67.7
Range19.4–95.9
Gender
 Male% (n/N)52.7% (154/292)
 Female% (n/N)47.3% (138/292)
Race/ethnicity
 American Indian/Alaska Native% (n/N)0.0% (0/292)
 Asian% (n/N)1.0% (3/292)
 Black or African American% (n/N)14.4% (42/292)
 Hispanic or Latino% (n/N)6.2% (18/292)
 Native Hawaiian/Pacific Islander% (n/N)0.0% (0/292)
 White% (n/N)79.1% (231/292)
Time from symptom onset to baseline (h)Mean±SD7.7±2.8
Median7.3
Range1.8–13.8
Baseline NIHSSn292
Mean±SD10.6±4.2
Median10.0
Range2.0–19.0
Side of infarct
 Right% (n/N)43.6% (123/282)
 Left% (n/N)56.4% (159/282)
 Medical history N=292
General history
 Diabetes mellitus% (n/N)21.2% (62/292)
 Insulin-dependent diabetes% (n/N)7.5% (22/292)
 Non-insulin dependent diabetes% (n/N)13.7% (40/292)
 Diabetes mellitus or new diagnosis within 30 days of enrollment% (n/N)32.5% (95/292)
 Hypertension% (n/N)71.2% (208/292)
 Hypertension or new diagnosis within 30 days of enrollment% (n/N)79.1% (231/292)
 Hyperlipidemia% (n/N)52.1% (152/292)
Current smoker% (n/N)28.8% (84/292)
Neurological history
 Cerebral ischemic infarct (stroke)% (n/N)15.8% (46/292)
 Transient ischemic attack% (n/N)11.3% (33/292)
 Seizure% (n/N)3.4% (10/292)
Cardiovascular history
 Atrial fibrillation% (n/N)23.3% (68/292)
 Atrial fibrillation or new diagnosis within 30 days of enrollment% (n/N)28.4% (83/292)
 Valvular disease/replacement% (n/N)6.2% (18/292)
 Peripheral vascular disease% (n/N)5.5% (16/292)
 Percutaneous transluminal coronary angioplasty% (n/N)9.2% (27/292)
 Coronary artery bypass graft% (n/N)10.6% (31/292)
 Myocardial infarction% (n/N)12.0% (35/292)
 Angina% (n/N)8.2% (24/292)
  • NIHSS, National Institutes of Health Stroke Scores.